肢端肥大症
医学
奥曲肽
垂体腺瘤
生长抑素
腺瘤
内分泌系统
内分泌疾病
一线治疗
生长激素
Pegvisomant公司
内科学
经蝶手术
胃肠病学
激素
化疗
作者
Maria Fleseriu,Lisa B. Nachtigall,Susan L. Samson,Шломо Мелмед
标识
DOI:10.1080/17446651.2024.2363540
摘要
Acromegaly is a rare endocrine disorder usually caused by a benign growth hormone‒secreting pituitary adenoma. Surgical adenoma resection is typically the first line of treatment, and medical therapy is used for patients with persistent disease following surgery, for adenoma recurrence, or for patients ineligible for, or declining, surgery. Approved somatostatin receptor ligands (SRLs) have been limited to injectable options, until recently. Oral octreotide capsules (OOC) are the first approved oral SRL for patients with acromegaly.
科研通智能强力驱动
Strongly Powered by AbleSci AI